These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 19110660

  • 1. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 2. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 3. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 4. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN.
    Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of membrane TNF-alpha on activated peripheral CD8+ T cells in systemic lupus erythematosus.
    Horiuchi T, Morita C, Tsukamoto H, Mitoma H, Sawabe T, Harashima S, Kashiwagi Y, Okamura S.
    Int J Mol Med; 2006 May; 17(5):875-9. PubMed ID: 16596274
    [Abstract] [Full Text] [Related]

  • 6. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 7. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
    Takasaki Y, Ogaki M, Abe K, Takeuchi K, Ando S, Tokano Y, Kobayashi S, Sekigawa I, Tsuda H, Hashimoto H.
    J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
    [Abstract] [Full Text] [Related]

  • 8. Abnormal differentiation of memory T cells in systemic lupus erythematosus.
    Fritsch RD, Shen X, Illei GG, Yarboro CH, Prussin C, Hathcock KS, Hodes RJ, Lipsky PE.
    Arthritis Rheum; 2006 Jul; 54(7):2184-97. PubMed ID: 16802356
    [Abstract] [Full Text] [Related]

  • 9. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 10. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto H.
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [Abstract] [Full Text] [Related]

  • 12. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
    Mellor-Pita S, Citores MJ, Castejon R, Yebra-Bango M, Tutor-Ureta P, Rosado S, Andreu JL, Vargas JA.
    Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
    [Abstract] [Full Text] [Related]

  • 13. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH.
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [Abstract] [Full Text] [Related]

  • 14. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [Abstract] [Full Text] [Related]

  • 15. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.
    Pool AJ, Whipp BJ, Skasick AJ, Alavi A, Bland JM, Axford JS.
    Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581
    [Abstract] [Full Text] [Related]

  • 16. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M.
    Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
    [Abstract] [Full Text] [Related]

  • 17. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Portales-Cervantes L, Niño-Moreno P, Doníz-Padilla L, Baranda-Candido L, García-Hernández M, Salgado-Bustamante M, González-Amaro R, Portales-Pérez D.
    Hum Immunol; 2010 Aug; 71(8):818-25. PubMed ID: 20493226
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL, Wang HJ, Ji XH, Li YY, Xuan HB, Heng C, Li YF.
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [Abstract] [Full Text] [Related]

  • 20. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease.
    Rus V, Zernetkina V, Puliaev R, Cudrici C, Mathai S, Via CS.
    Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.